Rossana Roncato

A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

Jesse J. Swen, Cathelijne H. van der Wouden, Lisanne E. N. Manson et al. · The Lancet · 2023 · 514 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Clinical validity of a <scp><i>DPYD</i></scp>‐based pharmacogenetic test to predict severe toxicity to fluoropyrimidines

Giuseppe Toffoli, Luciana Giodini, Angela Buonadonna et al. · International Journal of Cancer · 2015 · 91 citations · Full text

Medicine, Oncology, Pharmacology +17

Cisplatin resistance can be curtailed by blunting Bnip3-mediated mitochondrial autophagy

Caterina Vianello, Veronica Cocetta, Daniela Catanzaro et al. · Cell Death and Disease · 2022 · 58 citations · Full text

Life Sciences, Oncology, Pharmacology +17

The Genotype for <i><scp>DPYD</scp></i> Risk Variants in Patients With Colorectal Cancer and the Related Toxicity Management Costs in Clinical Practice

Giuseppe Toffoli, Federico Innocenti, Jerry Polesel et al. · Clinical Pharmacology & Therapeutics · 2018 · 53 citations

Medicine, Oncology, Pharmacology +17

Estimating the Effectiveness of DPYD Genotyping in Italian Individuals Suffering from Cancer Based on the Cost of Chemotherapy-Induced Toxicity

Vasileios Fragoulakis, Rossana Roncato, Chiara Dalle Fratte et al. · The American Journal of Human Genetics · 2019 · 52 citations · Full text

Medicine, Oncology, Pharmacoeconomics +14